Skip to main content
Premium Trial:

Request an Annual Quote

DiaCarta Clinical Services Laboratory Receives CLIA Certification

NEW YORK (GenomeWeb) – Molecular diagnostics developer DiaCarta announced today that its DiaCarta Clinical Services Laboratory has successfully passed the State of California survey under the Clinical Laboratory Improvement Amendments of 1988.

The lab now has permission to begin offering patient and clinical testing services for its QClamp-based molecular diagnostic. QClamp screens for tumor oncogenic driver and resistance mutations in tumor DNA derived from cancer patients.

The lab is located in Richmond, California, the company said, and specializes in patient testing and clinical trial services for gene mutation and gene expression monitoring, genotyping, and copy number analysis, as well as other molecular diagnostic tests. QClamp utilizes a sequence-specific xeno-nucleic acid clamp that suppresses PCR amplification on wild-type DNA and allows selective amplification of only the mutant template.

"We are very excited about the new addition of CLIA-certified clinical laboratory testing to our suite of product offerings," said Founder and CEO Aiguo Zhang in a statement. "Our CLIA certification is an important regulatory milestone and demonstrates our commitment to quality laboratory testing to provide accurate, reliable, and timely test results."

The company received a CE IVD mark for several of its QClamp line of real-time PCR-based mutation detection kits in February 2014.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.